ICU Medical (US.ICUI)
Capital Allocation Audit · Period: 2010 – 2026
Key Metrics
US.ICUI · YoY: 2026 Q1 vs 2025 Q1
| Metric | Value | YoY |
|---|---|---|
| FCF Conversion | 66.0% | → |
| ROE | 1.4% | ↑ |
| Cash Conversion | 129.1% | → |
| D/E Ratio | 0.63 | ↑ |
| Gross Margin | 38.9% | ↑ |
US.ICUI (ICU Medical) | YoY: 2026 Q1 vs 2025 Q1 Metric Value YoY ---------------------------- FCF Conversion 66.0% → ROE 1.4% ↑ Cash Conversion 129.1% → D/E Ratio 0.63 ↑ Gross Margin 38.9% ↑
Key Metrics
US.ICUI (ICU Medical) | YoY: 2026 Q1 vs 2025 Q1
Metric Value YoY----------------------------FCF Conversion 66.0% →ROE 1.4% ↑Cash Conversion 129.1% →D/E Ratio 0.63 ↑Gross Margin 38.9% ↑Audit Dimensions
Unlimited Companies
AppleMicrosoftAlphabet-AAmazonNVIDIAMeta PlatformsTeslaBerkshire Hathaway-BJPMorganVisaJohnson & JohnsonWalmartProcter & GambleExxon MobilUnitedHealthHome DepotMasterCardPfizerAbbVieCoca-ColaPepsiCoCostcoNetflixAdvanced Micro DevicesSalesforceDisneyNikeBoeingCaterpillarGoldman SachsAlibabaPDD HoldingsJD.comNIO IncLi AutoBaiduTaiwan SemiconductorASML HoldingEli Lilly and CoBroadcomCiscoOracleIntelAT&TVerizonMerck & CoTexas InstrumentsUnited Parcel ServiceRTX CorpLowe's Companies